In pancreatic and lung cancers, NETs were found to contain the matrix metallopeptidase 9 (MMP-9), a known accelerator of angiogenesis through the degradation of extracellular matrix by activated neutrophils which triggers vascular endothelial growth factor (VEGF) release (19). This evidence concerns the gene MMP9 and lung carcinoma.